trending Market Intelligence /marketintelligence/en/news-insights/trending/m64R4Aa4U1-D26vbppA_Hw2 content esgSubNav
In This List

SELLAS CFO resigns

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


SELLAS CFO resigns

SELLAS Life Sciences Group Inc. said Gene Mack resigned as the company's CFO and treasurer Dec. 17.

The company has engaged Aleksey Krylov as a consultant to provide financial services to the company for an initial term of three months. Krylov was the company's CFO from Oct. 24, 2017, through April 20, 2018.

The company also appointed John Burns, its vice president of finance and corporate controller, as the company's interim principal accounting officer.

New York-based SELLAS Life Sciences Group is a clinical-stage biopharmaceutical company that focuses on the development of novel cancer immunotherapies for various cancer indications.